The voice for compounding pharmacy
| December 20, 2019
Congress gives FDA direction on compounding in appropriation bill
Thanks to extensive advocacy by APC and its partners - and the help of our champions in Congress -
FDA's FY2020 spending bill includes directives from Congress:
Encouraging the Food and Drug Administration to work with the States before finalizing the Memorandum of Understanding on compounding regulation.
Noting awareness of concerns with the Food and Drug Administration's implementation of the Drug Quality Standards.
Encouraging the Food and Drug Administration to appoint a qualified voting member with recent, actual, and diverse pharmacy experience to the Pharmacy Compounding Advisory Committee.
Requiring FDA to provide a briefing to Congress on the agency's position on compounding with substances the subject of a USP dietary supplement monograph.
Here's a copy of the bill, which was signed by the president this week.